McNicoll Lewis & Vlak Starts ImmunoCellular Therapeutics (IMUC) at Buy
Tweet
Share
E-mailGet Alerts IMUC Hot Sheet
Price: $0.19 +26.67%
Rating Summary:
2 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Rating Summary:
2 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Join SI Premium – FREE
McNicoll Lewis & Vlak initiates coverage on ImmunoCellular Therapeutics (OTC: IMUC) with a Buy. PT $4.50.
For an analyst ratings summary and ratings history on ImmunoCellular Therapeutics click here. For more ratings news on ImmunoCellular Therapeutics click here.
Shares of ImmunoCellular Therapeutics closed at $2.76 yesterday.
For an analyst ratings summary and ratings history on ImmunoCellular Therapeutics click here. For more ratings news on ImmunoCellular Therapeutics click here.
Shares of ImmunoCellular Therapeutics closed at $2.76 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Starts Rocket Lab USA (RKLB) at Outperform
- CLSA Starts Shanghai Putailai New Energy (603659:CH) at High-Conviction Outperform (1)
- RBC Capital Starts Dell (DELL) at Outperform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
